Erwin S Schultz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Erwin S Schultz

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Immunological Reviews|November 26, 2002

Tumor-specific shared antigenic peptides recognized by human T cellsPierre Van Der Bruggen, Yi Zhang, Pascal Chaux, et al.

The Journal of Experimental Medicine|February 21, 2002

The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasomeErwin S Schultz, Jacques Chapiro, Christophe Lurquin, et al.

Cancer Immunology, Immunotherapy : CII|June 14, 2016

Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysisMarkus V Heppt, Thomas K Eigentler, Katharina C Kähler, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Immunological Reviews|November 26, 2002

Tumor-specific shared antigenic peptides recognized by human T cellsPierre Van Der Bruggen, Yi Zhang, Pascal Chaux, et al.

The Journal of Experimental Medicine|February 21, 2002

The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasomeErwin S Schultz, Jacques Chapiro, Christophe Lurquin, et al.

Cancer Immunology, Immunotherapy : CII|June 14, 2016

Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysisMarkus V Heppt, Thomas K Eigentler, Katharina C Kähler, et al.

Pageof 3